Skip to main content
    N

    Neurocrine Biosciences Inc (NBIX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $165.31
    -2.09 (-1.25%)

    Market Cap: $16.94B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Neurocrine Biosciences Inc (NBIX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Neurocrine Biosciences are United Therapeutics (UTHR), Kiniksa Pharmaceuticals (KNSA) and Elanco Animal Health (ELAN). Neurocrine Biosciences trades at 18.4x earnings, against a median of 19.7x for the 10 of these companies with a P/E. By market cap, Neurocrine Biosciences ranks 5th of the 13 companies on this page; Haleon (HLN) is the largest at $40.25B.

    Peer Comparison

    NBIX's revenue growth of 41.2% is above the peer median of 7.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Neurocrine Biosciences (NBIX)$16.94B18.4x4.5x19.0%N/A41.2%0.00%
    United Therapeutics Corporation (UTHR)$25.18B22.2x7.9x38.6%N/A4.1%0.00%
    Kiniksa Pharmaceuticals Ltd (KNSA)$7.57B72.5x7.8x11.6%N/A58.1%0.00%
    Elanco Animal Health (ELAN)$13.39B23.2x2.6x-2.9%1.6%11.3%0.00%
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)$7.45B21.4x2.2x4.2%11.6%10.0%0.00%
    Dr. Reddy’s Laboratories Ltd ADR (RDY)$12.29B39.6x3.5x8.5%5.7%-1.5%0.44%
    Lantheus Holdings Inc (LNTH)$6.64B17.9x4.5x17.3%14.8%1.5%0.00%
    Viatris Inc (VTRS)$23.87B8.1x1.6x-4.1%-0.2%-0.3%2.31%
    BioCryst Pharmaceuticals Inc (BCRX)$1.96B4.4x2.0x-37.4%24937.1%13.1%0.00%
    Supernus Pharmaceuticals, Inc. (SUPN)$1.52B12.7x2.0x32.8%N/A13.4%0.00%
    Haleon plc (HLN)$40.25BN/A1.6x14.5%13.9%2.2%2.12%
    Zoetis Inc (ZTS)$34.06B12.7x3.7x26.4%21.7%-1.3%2.51%
    BridgeBio Pharma Inc (BBIO)$15.25BN/A16.0x-59.8%-33.0%192.6%0.00%
    Peer median$12.84B19.7x3.0x10.0%11.6%7.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Neurocrine Biosciences, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Drug Manufacturers - Specialty & Generic; the other one is in Biotechnology.

    CompanyAboutPeers
    United Therapeutics Corporation (UTHR)Drug Manufacturers - Specialty & Generic
    United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs...
    UTHR competitors
    Kiniksa Pharmaceuticals Ltd (KNSA)Drug Manufacturers - Specialty & Generic
    Kiniksa Pharmaceuticals Ltd. (KNSA) is an innovative biopharmaceutical company focused on developing breakthrough therapies to address pressing unmet medical...
    KNSA competitors
    Elanco Animal Health (ELAN)Drug Manufacturers - Specialty & Generic
    Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals.
    ELAN competitors
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)Drug Manufacturers - Specialty & Generic
    Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms...
    AMRX competitors
    Dr. Reddy’s Laboratories Ltd ADR (RDY)Drug Manufacturers - Specialty & Generic
    Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
    RDY competitors
    Lantheus Holdings Inc (LNTH)Drug Manufacturers - Specialty & Generic
    Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment...
    LNTH competitors
    Viatris Inc (VTRS)Drug Manufacturers - Specialty & Generic
    Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
    VTRS competitors
    BioCryst Pharmaceuticals Inc (BCRX)Drug Manufacturers - Specialty & Generic
    BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
    BCRX competitors
    Supernus Pharmaceuticals, Inc. (SUPN)Drug Manufacturers - Specialty & Generic
    Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases...
    SUPN competitors
    Haleon plc (HLN)Drug Manufacturers - Specialty & Generic
    Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline...
    Zoetis Inc (ZTS)Drug Manufacturers - Specialty & Generic
    Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
    ZTS competitors
    BridgeBio Pharma Inc (BBIO)Biotechnology
    BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases.
    BBIO competitors

    Frequently Asked Questions About NBIX

    Who are Neurocrine Biosciences' main competitors?

    The companies most similar to Neurocrine Biosciences include United Therapeutics (UTHR), Kiniksa Pharmaceuticals (KNSA), Elanco Animal Health (ELAN), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) and Dr. Reddy’s Laboratories Ltd ADR (RDY), listed from the closest match.

    Who is Neurocrine Biosciences' biggest competitor?

    Haleon (HLN) is the largest of the similar companies at $40.25B; United Therapeutics (UTHR) is the closest match by business profile, size, sector and industry.

    How does NBIX stock compare with its competitors?

    NBIX's P/E is 18.4x against a peer median of 19.7x; its P/S is 4.5x against a peer median of 3.0x; its net margin is 19.0% against a peer median of 10.0%.

    Which of Neurocrine Biosciences' competitors pays a higher dividend?

    Neurocrine Biosciences pays no dividend. Zoetis (ZTS), Viatris (VTRS), Haleon (HLN) and Dr. Reddy’s Laboratories Ltd ADR (RDY) have higher forward dividend yields; Zoetis (ZTS) has the highest at 2.51%.

    Is Neurocrine Biosciences bigger than its competitors?

    No. Neurocrine Biosciences is 5th by market cap among the 13 companies on this page; the largest is Haleon (HLN) at $40.25B.